Self-Assembled nanoparticles Combining Berberine and Sodium Taurocholate for Enhanced Anti-Hyperuricemia Effect

References

• Feng X, Sureda A, Jafari S, et al. Berberine in cardiovascular and metabolic diseases: from mechanisms to therapeutics. Theranostics. 2019;9(7):1923–1951. doi:10.7150/thno.30787
   PubMed Web of Science ®Google Scholar
• Wang K, Feng X, Chai L, Cao S, Qiu F. The metabolism of berberine and its contribution to the pharmacological effects. Drug Metab Rev. 2017;49(2):139–157. doi:10.1080/03602532.2017.1306544
   PubMed Web of Science ®Google Scholar
• Yu Q, Li M, Chen H, et al. The discovery of berberine erythrocyte-hemoglobin self-assembly delivery system: a neglected carrier underlying its pharmacokinetics. Drug Deliv. 2022;29(1):856–870. doi:10.1080/10717544.2022.2036870
   PubMed Web of Science ®Google Scholar
• Panda DS, Eid HM, Elkomy MH, et al. Berberine encapsulated lecithin-chitosan nanoparticles as innovative wound healing agent in type II diabetes. Pharmaceutics. 2021;13(8):1197. doi:10.3390/pharmaceutics13081197
   PubMed Web of Science ®Google Scholar
• Dawson PA, Hubbert ML, Rao A. Getting the mOST from OST: role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism. Biochim Biophys Acta. 2010;1801(9):994–1004. doi:10.1016/j.bbalip.2010.06.002
   PubMed Web of Science ®Google Scholar
• Brufau G, Groen AK, Kuipers F. Reverse cholesterol transport revisited: contribution of biliary versus intestinal cholesterol excretion. Arterioscler Thromb Vasc Biol. 2011;31(8):1726–1733. doi:10.1161/ATVBAHA.108.181206
   PubMed Web of Science ®Google Scholar
• Mathavan S, Mikov M, Golocorbin-Kon S, Al-Salami H. Diabetes development increased concentrations of the conjugated bile acid, taurocholic acid in serum, while treatment with microencapsulated-taurocholic acid exerted no hypoglycaemic effects. Eur J Pharm Sci. 2017;106:1–9. doi:10.1016/j.ejps.2017.05.041
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes. 2016;7(3):201–215. doi:10.1080/19490976.2016.1150414
   PubMed Web of Science ®Google Scholar
• Biagioli M, Marchiano S, Carino A, et al. Bile acids activated receptors in inflammatory bowel disease. Cells. 2021;10(6):1281. doi:10.3390/cells10061281
   PubMed Web of Science ®Google Scholar
• Quinones JP, Peniche H, Peniche C. Chitosan based self-assembled nanoparticles in drug delivery. Polymers. 2018;10(3):235. doi:10.3390/polym10030235
   PubMed Web of Science ®Google Scholar
• Fei J, Zhao J, Du C, et al. One-pot ultrafast self-assembly of autofluorescent polyphenol-based core@shell nanostructures and their selective antibacterial applications. ACS Nano. 2014;8(8):8529–8536. doi:10.1021/nn504077c
   PubMed Web of Science ®Google Scholar
• Wang D, Yu C, Xu L, et al. Nucleoside analogue-based supramolecular nanodrugs driven by molecular recognition for synergistic cancer therapy. J Am Chem Soc. 2018;140(28):8797–8806. doi:10.1021/jacs.8b04556
   PubMed Web of Science ®Google Scholar
• Li T, Wang P, Guo W, et al. Natural berberine-based Chinese herb medicine assembled nanostructures with modified antibacterial application. ACS Nano. 2019;13(6):6770–6781. doi:10.1021/acsnano.9b01346
   PubMed Web of Science ®Google Scholar
• Jiao JM, Xu GY, Xin X. Effect of bile salts on self-assembly and construction of micro-/nanomaterials. Acta Phys Chim Sin. 2019;35(7):684–696. doi:10.3866/PKU.WHXB201806056
   Web of Science ®Google Scholar
• Huang J, Ma ZF, Zhang Y, et al. Geographical distribution of hyperuricemia in mainland China: a comprehensive systematic review and meta-analysis. Glob Health Res Policy. 2020;5(1):52. doi:10.1186/s41256-020-00178-9
   PubMedGoogle Scholar
• Komori H, Yamada K, Tamai I. Hyperuricemia enhances intracellular urate accumulation via down-regulation of cell-surface BCRP/ABCG2 expression in vascular endothelial cells. Biochim Biophys Acta Biomembr. 2018;1860(5):973–980. doi:10.1016/j.bbamem.2018.01.006
   PubMed Web of Science ®Google Scholar
• Liu C, Zhou HN, Zhang RR, et al. Anti-hyperuricemic and nephroprotective effect of geniposide in chronic hyperuricemia mice. J Funct Foods. 2019;2019:61.
   Google Scholar
• Su HY, Yang C, Liang D, Liu HF. Research advances in the mechanisms of hyperuricemia-induced renal injury. Biomed Res Int. 2020;2020:5817348. doi:10.1155/2020/5817348
   PubMed Web of Science ®Google Scholar
• Zhang C, Li L, Zhang Y, Zeng C. Recent advances in fructose intake and risk of hyperuricemia. Biomed Pharmacother. 2020;131:110795. doi:10.1016/j.biopha.2020.110795
   PubMed Web of Science ®Google Scholar
• Xu L, Lu LL, Gao JD. Traditional Chinese herbal medicine plays a role in the liver, kidney, and intestine to ameliorate hyperuricemia according to experimental studies. Evid Based Complement Alternat Med. 2021;2021:4618352. doi:10.1155/2021/4618352
   PubMedGoogle Scholar
• Yanai H, Adachi H, Hakoshima M, Katsuyama H. Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease. Int J Mol Sci. 2021;22(17):9221. doi:10.3390/ijms22179221
   PubMed Web of Science ®Google Scholar
• Xu L, Lin G, Yu Q, et al. Anti-hyperuricemic and nephroprotective effects of dihydroberberine in potassium oxonate- and hypoxanthine-induced hyperuricemic mice. Front Pharmacol. 2021;12:645879. doi:10.3389/fphar.2021.645879
   PubMed Web of Science ®Google Scholar
• Braga TT, Foresto-Neto O, Camara NOS. The role of uric acid in inflammasome-mediated kidney injury. Curr Opin Nephrol Hypertens. 2020;29(4):423–431. doi:10.1097/MNH.0000000000000619
   PubMed Web of Science ®Google Scholar
• Wang XJ, Qi YD, Guan HC, et al. Gegen Qinlian decoction ameliorates hyperuricemia-induced renal tubular injury via blocking the inflammatory signaling pathway. Front Pharmacol. 2021;12:665398. doi:10.3389/fphar.2021.665398
   PubMed Web of Science ®Google Scholar
• Jiang L, Wu Y, Qu C, et al. Hypouricemic effect of gallic acid, a bioactive compound from Sonneratia apetala leaves and branches, on hyperuricemic mice. Food Funct. 2022;13(19):10275–10290. doi:10.1039/D2FO02068H
   PubMed Web of Science ®Google Scholar
• Zhang M, Solomon DH, Desai RJ, et al. Assessment of cardiovascular risk in older patients with gout initiating febuxostat versus allopurinol: population-based cohort study. Circulation. 2018;138(11):1116–1126. doi:10.1161/CIRCULATIONAHA.118.033992
   PubMed Web of Science ®Google Scholar
• Azadi R, Mousavi SE, Kazemi NM, Yousefi-Manesh H, Rezayat SM, Jaafari MR. Anti-inflammatory efficacy of Berberine nanomicelle for improvement of cerebral ischemia: formulation, characterization and evaluation in bilateral common carotid artery occlusion rat model. BMC Pharmacol Toxicol. 2021;22(1):54. doi:10.1186/s40360-021-00525-7
   PubMed Web of Science ®Google Scholar
• Du J, Zong L, Li M, et al. Two-pronged anti-tumor therapy by a new polymer-paclitaxel conjugate micelle with an anti-multidrug resistance effect. Int J Nanomedicine. 2022;17:1323–1341. doi:10.2147/IJN.S348598
   PubMed Web of Science ®Google Scholar
• Chau YT, Chen HY, Lin PH, Hsia SM. Preventive effects of fucoidan and fucoxanthin on hyperuricemic rats induced by potassium oxonate. Mar Drugs. 2019;17(6). doi:10.3390/md17060343
   Web of Science ®Google Scholar
• Chen J, Xu L, Jiang L, et al. Sonneratia apetala seed oil attenuates potassium oxonate/hypoxanthine-induced hyperuricemia and renal injury in mice. Food Funct. 2021;12(19):9416–9431. doi:10.1039/D1FO01830B
   PubMed Web of Science ®Google Scholar
• Li Q, Huang Z, Liu D, et al. Effect of berberine on hyperuricemia and kidney injury: a network pharmacology analysis and experimental validation in a mouse model. Drug Des Devel Ther. 2021;15:3241–3254. doi:10.2147/DDDT.S317776
   PubMed Web of Science ®Google Scholar
• Song D, Hao J, Fan D. Biological properties and clinical applications of berberine. Front Med. 2020;14(5):564–582. doi:10.1007/s11684-019-0724-6
   PubMed Web of Science ®Google Scholar
• Xiang X, Han Y, Neuvonen M, Laitila J, Neuvonen PJ, Niemi M. High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878(1):51–60. doi:10.1016/j.jchromb.2009.11.019
   PubMed Web of Science ®Google Scholar
• Yang Y, He J, Suo Y, et al. Anti-inflammatory effect of taurocholate on TNBS-induced ulcerative colitis in mice. Biomed Pharmacother. 2016;81:424–430. doi:10.1016/j.biopha.2016.04.037
   PubMed Web of Science ®Google Scholar
• Rane SS, Choi P. Polydispersity index: how accurately does it measure the breadth of the molecular weight distribution? Chem Mater. 2005;17(4):926. doi:10.1021/cm048594i
   Web of Science ®Google Scholar
• Tantra R, Schulze P, Quincey P. Effect of nanoparticle concentration on zeta-potential measurement results and reproducibility. Particuology. 2010;8(3):279–285. doi:10.1016/j.partic.2010.01.003
   Web of Science ®Google Scholar
• Kakran M, Shegokar R, Sahoo NG, Shaal LA, Li L, Muller RH. Fabrication of quercetin nanocrystals: comparison of different methods. Eur J Pharm Biopharm. 2012;80(1):113–121. doi:10.1016/j.ejpb.2011.08.006
   PubMed Web of Science ®Google Scholar
• Manabe N, Hanada S, Aoki N, Futamura Y, Yamamoto K, Adschiri T. Flocculation and re-dispersion of colloidal quantum dots. J Chem Eng Jpn. 2012;45(11):917–923. doi:10.1252/jcej.12we114
   Web of Science ®Google Scholar
• Dou YX, Zhou JT, Wang TT, et al. Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. Int J Nanomedicine. 2018;13:5887–5907. doi:10.2147/IJN.S174146
   PubMed Web of Science ®Google Scholar
• Trenkenschuh E, Friess W. Freeze-thaw stability of aluminum oxide nanoparticles. Int J Pharm. 2021;606:120932. doi:10.1016/j.ijpharm.2021.120932
   PubMedGoogle Scholar
• Almalik A, Alradwan I, Kalam MA, Alshamsan A. Effect of cryoprotection on particle size stability and preservation of chitosan nanoparticles with and without hyaluronate or alginate coating. Saudi Pharm J. 2017;25(6):861–867. doi:10.1016/j.jsps.2016.12.008
   PubMed Web of Science ®Google Scholar
• Kaszuba M, Corbett J, Watson FM, Jones A. High-concentration zeta potential measurements using light-scattering techniques. Philos Trans a Math Phys Eng Sci. 2010;368(1927):4439–4451. doi:10.1098/rsta.2010.0175
   PubMed Web of Science ®Google Scholar
• Sultana S, Alzahrani N, Alzahrani R, et al. Stability issues and approaches to stabilised nanoparticles based drug delivery system. J Drug Target. 2020;28(5):468–486. doi:10.1080/1061186X.2020.1722137
   PubMed Web of Science ®Google Scholar
• Lin G, Yu Q, Xu L, et al. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway. Eur J Pharmacol. 2021;912:174592. doi:10.1016/j.ejphar.2021.174592
   PubMed Web of Science ®Google Scholar
• Guo Y, Yu Y, Li H, et al. Inulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice. Eur J Nutr. 2021;60(4):2217–2230. doi:10.1007/s00394-020-02414-x
   PubMed Web of Science ®Google Scholar
• Wu YL, Chen JF, Jiang LY, et al. The extract of sonneratia apetala leaves and branches ameliorates hyperuricemia in mice by regulating renal uric acid transporters and suppressing the activation of the JAK/STAT Signaling Pathway. Front Pharmacol. 2021;12:698219. doi:10.3389/fphar.2021.698219
   PubMed Web of Science ®Google Scholar
• Yong T, Chen S, Xie Y, et al. Hypouricemic effects of ganoderma applanatum in hyperuricemia mice through OAT1 and GLUT9. Front Pharmacol. 2017;8:996. doi:10.3389/fphar.2017.00996
   PubMed Web of Science ®Google Scholar